Joel M. Reid

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism

Juliana Camacho-Pereira, Mariana G. Tarragó, Claudia C.S. Chini et al. · Cell Metabolism · 2016 · 830 citations · Full text

Age-related Nad Decline, Aging, Mitochondrial Function +10

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Patricia LoRusso, Alex A. Adjei, Mary Varterasian et al. · Journal of Clinical Oncology · 2005 · 397 citations

Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles

Rochelle R. Arvizo, Oscar R. Miranda, Daniel F. Moyano et al. · PLoS ONE · 2011 · 380 citations · Full text

Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent

Chitta Ranjan Patra, Resham Bhattacharya, Enfeng Wang et al. · Cancer Research · 2008 · 367 citations

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Evanthia Galanis, Kurt A. Jaeckle, Matthew J. Maurer et al. · Journal of Clinical Oncology · 2009 · 354 citations · Full text